Case Number 6466
Request Date 10/01/2019
Completion Date 12/02/2019

 

Details of the Request

1. In your trust, in the past 3 months [latest 3 months available], how many asthma patients aged 18 and over have been treated [with a drug]?

2. How many paediatric asthma treated patients [aged 6-17] have been treated in the last 3 months?

3. How many severe asthmatic patients [BTS guidelines, step 4 or 5] have been treated in the last 3 months?

4. How many patients have been treated in the last 3 months with:

  • Omalizumab [Xolair]
  • Mepolizumab [Nucala]
  • Reslizumab [Cinqaero]
  • Benralizumab [Fasenra]
  • Other [Please state]

5. How many paediatric patients have treated in the last 3 months with Xolair / omalizumab?

6. Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs ;

  • Ocreotide
  • Lanreotide
  • Pasireotide
  • Pegvisomant

 

Details of the Response

1. In your trust, in the past 3 months [latest 3 months available], how many asthma patients aged 18 and over have been treated [with a drug]?

For this question we have used data for all inpatient admissions in the past 3 months that have a diagnosis code for asthma and this figure is:

397 patients aged 18 and over.

Not included in this figure is the quantity of patients seen as outpatients for Omalizumab as this figure is included in question 4 below.

 

2. How many paediatric asthma treated patients [aged 6-17] have been treated in the last 3 months?

As above in question 1 we have used data for all inpatient admissions in the past 3 months that have a diagnosis code for asthma and this figure is 18 paediatric patients aged 6-17.

Not included in this figure is the quantity of paediatric patients seen as outpatients for Omalizumab as the trust does not treat paediatric patients in this manner as stated in question 5 below.

 

3. How many severe asthmatic patients [BTS guidelines, step 4 or 5] have been treated in the last 3 months?

The Trust does not hold this data.

 

4. How many patients have been treated in the last 3 months with:

Omalizumab [Xolair] 31
Mepolizumab [Nucala] 0
Reslizumab [Cinqaero] 0
Benralizumab [Fasenra] 0
Other [Please state] 0

 

5. How many paediatric patients have treated in the last 3 months with Xolair/omalizumab?

The trust does not treat paediatric patients with Omalizumab

 

6. Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs ;

Ocreotide 16
Lanreotide 2
Pasireotide 0
Pegvisomant 0